Varian to Present at the Citi Global Healthcare Conference
PALO ALTO, Calif., Nov. 19, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced that Gary Bischoping, chief financial officer, will present at the Citi Global Healthcare Conference in New York City, scheduled for 11:00 a.m. Eastern Time on December 5, 2018.
Information about the webcast of the company's presentation will be available through a link on the company website at www.varian.com/investors.
About Varian Varian is a leader in developing and delivering cancer care solutions and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 7,000 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Investor Relations Contact
J. Michael Bruff Senior Vice President, Investor Relations +1 (650) 424-5163 [email protected]
Press Contact
Mark Plungy Director, Public Relations +1 (650) 424-5630 [email protected]
Evermore Cannabis Company, a leader in innovative cannabis cultivation and product development, is thrilled to announce its remarkable success at the first-ever Maryland Leaf Bowl, held on April 13th. Demonstrating excellence across multiple...
Autolomous, the market-leading developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq, industry-leading clinical-phase Cell Therapy CDMO (contract development and manufacturing organization), announce a...
As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new study, a team from Children's Hospital of Philadelphia (CHOP) used state-of-the-art...
The Atrium at Cardinal Drive, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the second straight year. In U.S. News & World Report's third...
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is proud to announce the recipients of the 2024 ADLM and Academy of Diagnostics & Laboratory Medicine Awards. Through this annual awards program, ADLM and its Academy...
